Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Influenza vaccine for all?

Ross Upshur
CMAJ April 26, 2005 172 (9) 1161-1162; DOI: https://doi.org/10.1503/cmaj.1041716
Ross Upshur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2005 CMA Media Inc. or its licensors

I find it interesting that, a few weeks after celebrating the achievements of the Cochrane Collaboration,1 CMAJ published a systematic review2 and a recommendation statement from the Canadian Task Force on Preventive Health Care3 on preventing influenza in the general population (and the authors of the systematic review were quoted in the lay press as endorsing universal vaccination4), when a Cochrane review of the topic5 already exists.

The Cochrane systematic review,5 alluded to but not cited by Joanne Langley and Marie Faughnan,2 concludes that “[i]nfluenza vaccines are effective in reducing serologically confirmed cases of influenza. However, they are not as effective in reducing cases of clinical influenza and number of working days lost. Universal immunisation of healthy adults is not supported by the results of this review.”

Langley and Faughnan2 state that their goal was to determine the efficacy of the vaccine, not the efficacy of a universal vaccination program. Yet it appears that they, and the task force, endorse such a strategy, without evidence related to a variety of ancillary considerations that they identify (including economic costs, vaccine procurement and public acceptability).

Something is missing here. Was the CMAJ systematic review not the compelling piece of evidence leading to the task force's endorsement of universal vaccination? Was the conclusion of the Cochrane Collaboration wrong? Is there evidence of cost-effectiveness, and have procurement issues been sorted out? Just how many systematic reviews do we need on a particular topic?

R.A. Fisher, the pioneering methodologist for randomized trials and the most influential statistician of the 20th century,6 envisioned controlled trials (and, by extension, systematic reviews and meta-analyses) as an essential technique to reduce the interpretive variability of study results. I wish he and Archie Cochrane were still around to help us sort this out.

Footnotes

  • Competing interests: None declared.

References

  1. 1.↵
    The Cochrane Collaboration at 10: kudos and challenges [editorial]. CMAJ 2004;171(7):701.
    OpenUrlFREE Full Text
  2. 2.↵
    Langley JM, Faughnan ME. Prevention of influenza in the general population. CMAJ 2004;171(10):1213-22.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Langley JM, Faughnan ME; Canadian Task Force on Preventive Health Care. Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2004;171(10):1169-70.
    OpenUrlFREE Full Text
  4. 4.↵
    Picard A. MDs back flu shots for every Canadian. The Globe and Mail [Toronto] 2004 Nov 9; Sect A:1.
  5. 5.↵
    Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. In: The Cochrane Library; Issue 3, 2004. Oxford: Update Software.
  6. 6.↵
    R.A. Fisher digital archive. Adelaide, Australia: University of Adelaide Library; 2004.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 172 (9)
CMAJ
Vol. 172, Issue 9
26 Apr 2005
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Influenza vaccine for all?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Influenza vaccine for all?
Ross Upshur
CMAJ Apr 2005, 172 (9) 1161-1162; DOI: 10.1503/cmaj.1041716

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Influenza vaccine for all?
Ross Upshur
CMAJ Apr 2005, 172 (9) 1161-1162; DOI: 10.1503/cmaj.1041716
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Highlighting obesity as a risk factor for endometrial cancer
  • Hepatitis B vaccination for Canadian children: time for an adult conversation
  • Codesigning a public health approach to preventing firearm-related suicide deaths with rural communities
Show more Letters

Similar Articles

Collections

  • Topics
    • Infectious diseases

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire